MRK NYSE
Merck & Co., Inc.
1W: +2.2%
1M: +2.6%
3M: -5.2%
YTD: +8.8%
1Y: +52.9%
3Y: +8.6%
5Y: +80.3%
$122.41
+6.53 (+5.64%)
Weekly Expected Move ±3.4%
$104
$108
$111
$115
$119
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.45
Bullish
3 bullish
0 neutral
1 bearish
Articles (24h)
4
Hourly Sentiment (24h)
0.24
Neutral
9 bullish
1 neutral
5 bearish
Articles (7d)
15
Daily Sentiment (7 Days)
Articles (100)
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
Dow Jones Hits Record Highs, DELL Jumps 15%: Stock Market Today
Will Weak Gardasil Sales Continue to Ail MRK's Vaccines Sales in 2026?
Here's Why You Should Add SMMT Stock to Your Portfolio Now
AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell?
Eli Lilly vs. Merck: Which Pharma Stock Looks Stronger Now?
EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion
Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study
Regeneron's Late-Stage Melanoma Study Misses Primary Goal
Why Is Regeneron Stock Sinking Monday?
Regeneron hit with late-stage trial setback for Libtayo combo against Merck’s Keytruda
FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'
Trump 'Most Favored Nation' drug policy risks China R&D takeover
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
Will Keytruda Continue to Aid MRK's Growth in 2026 After a Strong Q1?
1 Dividend ETF Quietly Outperforming the Market Right Now
Moderna's Revenues See Strong International Momentum in Q1 Earnings
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
Top Research Reports for UnitedHealth, Merck & Qualcomm
Inhibrx Cancer Treatment Shows High Response Rates In Head And Neck Cancer Study
Merck Stock Down 7% in a Month: Should Investors Hold or Exit?
Trump says unaware of a plan to fire FDA commissioner
Inhibrx rises on upcoming interim mid-stage data for head and neck cancer asset
2 Dividend Stocks to Double Up On Right Now
Trump to fire FDA commissioner Marty Makary: WSJ
Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus
Merck & Co. picks Salesforce AI CRM to build 360° animal health platform
Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier
FDA halts publication of studies on COVID, shingles vaccines
3 Monster Dividend Stocks That Could Pay You Through the Next Decade of Chaos
SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Earnings Scoreboard: 82% of S&P 500 reporting firms top EPS estimates as 78% of firms post Y/Y earnings growth
S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
MRK Q1 Earnings & Sales Beat Estimates, 2026 Sales View Tightened
Merck (MRK) Q1 2026 Earnings Call Transcript
Merck Swings To Quarterly Loss On Cidara Deal
Pharma stocks rebound on cheap valuations, patent cliff fears ease, UBS says—CNBC interview
Jobless Claims Come in Extremely Low
Econ Growth, Historically Low Jobless Claims & More Earnings
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates
Earnings Scheduled For April 30, 2026
Merck Q1 earnings beat lifts shares; 2026 guidance narrowed
Merck in charts: KEYTRUDA +11.5% Y/Y in Q1; Gardasil -19%, Januvia -28%
Earnings Snapshot: Merck FY outlook misses estimate; guidance excludes Terns deal, flags $5.8B charge
Merck beats top-line and bottom-line estimates; narrows FY26 outlook
Merck Q1 Preview: Analysts pin hopes on Keytruda, Winrevair for strong Q1 print
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
AZN Q1 Earnings and Sales Beat, Key Drugs Offset Generic Pressure
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Moderna Gears Up to Report Q1 Earnings: Here's What to Expect
Merck & Co., Inc. $MRK Shares Bought by AMG National Trust Bank
IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts
IBRX: What Anktiva's Bladder Data Says About 2026 Sales
Will These 5 Drug Bigwigs Surpass Q1 Earnings Forecasts?
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?
Exploring Analyst Estimates for Merck (MRK) Q1 Earnings, Beyond Revenue and EPS
D.A. Davidson & CO. Raises Stake in Merck & Co., Inc. $MRK
Ashton Thomas Private Wealth LLC Sells 49,784 Shares of Merck & Co., Inc. $MRK
FARMERS & MERCHANTS TRUST Co OF LONG BEACH Sells 4,880 Shares of Merck & Co., Inc. $MRK
Comerica Bank Reduces Position in Merck & Co., Inc. $MRK
Aprio Wealth Management LLC Has $3.66 Million Stock Position in Merck & Co., Inc. $MRK
Anchyra Partners LLC Purchases New Position in Merck & Co., Inc. $MRK
Advisors Capital Management LLC Has $17.34 Million Holdings in Merck & Co., Inc. $MRK
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
Sun Pharma to buy Organon in $11.75B deal, expanding global reach
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Brindle & Bay Financial Advisors LLC Invests $778,000 in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stake Increased by AEGON ASSET MANAGEMENT UK Plc
Earnings Scoreboard: 82% of S&P 500 early reporters top EPS estimates ahead of big tech wave
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
Merck acquisition of Terns passes HSR waiting period expiration
Will Lower Gardasil Sales Hurt MRK's Vaccines Sales in Q1 Earnings?
Organon climbs amid reports of $13B buyout bid from Sun Pharma
Arizona State Retirement System Sells 31,306 Shares of Merck & Co., Inc. $MRK
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q1 Earnings
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC
B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in Merck & Co., Inc. $MRK
Merck inks AI deal worth up to $1B with Google Cloud
Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study
Inhibrx cancer drug reportedly drawing interest of Merck and rivals
CPC Advisors LLC Increases Position in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp
Merck gains approval of HIV drug regimen Idvynso
Why Is Merck Stock Falling Tuesday?
Why Is Merck Stock Falling Tuesday?